Development of a New 1,2,4-Butanetriol Biosynthesis Pathway in an Engineered Homoserine-producing Strain of Escherichia Coli

Yujun Zhang,Lin Chen,Arthur H. Thomas,An‐Ping Zeng
DOI: https://doi.org/10.35534/sbe.2023.10007
2023-01-01
Abstract:: 1,2,4-butanetriol (BT) is a compound of high interest with applications in pharmaceutical and materials. In this work, we designed a novel biosynthetic pathway for BT from glucose via a nonessential amino acid homoserine. This non-natural pathway used an engineered phosphoserine transaminase (SerC R42W/R77W ) to achieve the deamination of homoserine to 4-hydroxy-2-oxobutanoic acid (HOBA). Three consecutive enzymes including a lactate dehydrogenase, a 4-hydroxybutyrate CoA-transferase and a bifunctional aldehyde/alcohol dehydrogenase are used to catalyze HOBA to BT. To enhance the carbon flux to homoserine, a homoserine-producing Escherichia coli was developed by improving the overexpression of two relevant key genes met L and lys C (V339A). The simultaneous overexpression of the genes encoding these enzymes for the homoserine-derived BT pathway enabled production of 19.6 mg/L BT from glucose in the homoserine-producing E. coli .
What problem does this paper attempt to address?